5-year follow-up of 120 of 236 adults with arthralgia at increased RA risk: glucocorticoid injection plus 1 year of methotrexate vs placebo cut RA in ACPA-negative (9% vs 32%; HR 0·24) but not ACPA-positive people (58% vs 65%; HR 0·75); no clear effect in full cohort.
RCTn = 236
Mulligen et al. Long-term durability of a time-limited methotrexate intervention in patients with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative arthralgia at increased risk for rheumatoid arthritis (TREAT EARLIER): 5-year data from a double-blind, randomised, placebo-controlled trial